Oncological outcomes of laparoscopic surgery of liver metastases: a single-centre experience

被引：14

作者：

Cipriani F. ^{[1
]}

Rawashdeh M. ^{[1
]}

Ahmed M. ^{[1
]}

Armstrong T. ^{[1
]}

Pearce N.W. ^{[1
]}

Abu Hilal M. ^{[1
]}

机构：

[1] University Hospital Southampton NHS Foundation Trust, E level, Tremona Road, Southampton

来源：

Updates in Surgery | 2015年 / 67卷 / 2期

关键词：

Laparoscopic hepatectomy; Laparoscopic liver resection; Liver metastases; Long-term outcomes; Oncological outcomes;

D O I：

10.1007/s13304-015-0308-1

中图分类号：

学科分类号：

摘要：

In the era of multimodal management of liver metastases, surgical resection remains the only curative option, with open approach still being referred to as the standard of care. Currently, the feasibility and benefits of the laparoscopic approach for liver resection have been largely demonstrated. However, its oncologic adequacy remains to be confirmed. The aim of this study is to report the oncological results of laparoscopic liver resection for metastatic disease in a single-centre experience. A single-centre database of 413 laparoscopic liver resections was reviewed and procedures for liver metastases were selected. The assessment of oncologic outcomes included analysis of minimal tumour-free margin, R1 resection rate and 3-year survival. The feasibility and safety of the procedures were also evaluated through analysis of perioperative outcomes. The study comprised 209 patients (294 procedures). Colorectal liver metastases were the commonest indication (67.9 %). Fourteen patients had conversion (6.7 %) and oncological concern was the commonest reason for conversion (42.8 %). Median tumour-free margin was 10 mm and complete radical resections were achieved in 211 of 218 curative-intent procedures (96.7 %). For patients affected by colorectal liver metastases, 1- and 3-year OS resulted 85.9 and 66.7 %. For patients affected by neuroendocrine liver metastases, 1- and 3-year OS resulted 93 and 77.8 %. Among the patients with metastases from other primaries, 1- and 3-year OS were 83.3 and 70.5 %. The laparoscopic approach is a safe and valid option in the treatment of patients with metastatic liver disease undergoing curative resection. It does offer significant perioperative benefits without compromise of oncologic outcomes. © 2015, Italian Society of Surgery (SIC).

引用

页码：185 / 191

页数：6

共 39 条

[1]

Siegel R.L., Miller K.D., Jemal A., Cancer statistics, CA Cancer J Clin, 65, 1, pp. 5-29, (2015)

[2]

Stuart-Harris R., Shadbolt B., Palmqvist C., Chaudri Ross H.A., The prognostic significance of single hormone receptor positive metastatic breast cancer: an analysis of three randomised phase III trials of aromatase inhibitors, Breast, 18, 6, pp. 351-355, (2009)

[3]

Moltzer R.J., Mazumdar M., Bacik J., Berg W., Amsterdam A., Ferrara J., Survival and prognostic stratification of 670 patients with advanced renal cell carcinoma, J Clin Oncol, 17, 8, pp. 2530-2540, (1999)

[4]

Kopetz S., Chang G.J., Overman M.J., Eng C., Sargent D.J., Larson D.W., Grothey A., Vauthey J.N., Nargoney D.M., McWilliams R.R., Improved survival in metastatic colorectal cancer is associated with adoption of hepatic resection and improved chemotherapy, J Clin Oncol, 27, 22, pp. 3677-3683, (2009)

[5]

Reddy S.K., Zorzi D., Lum Y.W., Barbas A.S., Pawlik T.M., Ribero D., Abdalla E.K., Choti M.A., Kemp C., Vauthey J.N., Morse M.A., White R.R., Clary B.M., Timing of multimodality therapy for resectable synchronous colorectal liver metastases: a retrospective multi-institutional analysis, Ann Surg Oncol, 16, 7, pp. 1809-1819, (2009)

[6]

Gordon A.C., Gradishar W.J., Kaklamani V.G., Thuluvath A.J., Ryu R.K., Sato K.T., Gates V.L., Salme R., Lewandowski R.J., Yttrium-90 radioembolization stops progression of targeted breast cancer liver metastases after failed chemotherapy, J Vasc Interv Radiol, 25, 10, pp. 1523-1532, (2014)

[7]

Tomlinson J.S., Janargin W.R., DeMatteo R.P., Fong Y., Kornprat P., Gonen M., Kemeny N., Brennan M.F., Blumgart L.H., D'Angelica M., Actual 10-year survival after resection of colorectal liver metastases defines cure, J Clin Oncol, 25, 29, pp. 4575-4580, (2007)

[8]

Khatri V.P., Petrelli N.J., Belghiti J., Extending the frontiers of surgical therapy for hepatic colorectal metastases: is there a limit?, J Clin Oncol, 23, 33, pp. 8490-8499, (2005)

[9]

Tuttle T.M., Curley S.A., Roh M.S., Repeat hepatic resection as effective treatment of recurrent colorectal liver metastases, Ann Surg Oncol, 4, 2, pp. 125-130, (1997)

[10]

Tranchart H., Di Giuro G., Lainas P., Pourcher G., Devaquet N., Perlemuter G., Franco D., Dagher I., Laparoscopic liver resection with selective prior vascular control, Am J Surg, 205, 1, pp. 8-14, (2013)

← 1 2 3 4 →